Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Size Matters: Advanced Treatment of Acute Pulmonary Embolism Caused by a Large Snake-Like Thrombus.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

Med (New York, N.Y.)·2026
Same author

Clinical, Metabolic, and Virological Insights into Hepatitis C Virus-Infected Patients through the Combinatorial Metabolic Dysfunction-associated Steatotic Liver Disease Framework: Evidence from an Italian Cohort.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same author

Safety of Invasive Procedures During Adult Extracorporeal Membrane Oxygenation: A Systematic Review.

Journal of clinical medicine·2026
Same author

Orthohantavirus Infection Mimicking Acute Viral Hepatitis: An Underrecognized Clinical Presentation.

Pathogens (Basel, Switzerland)·2026
Same author

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

Cancer·2026

Related Experiment Video

Updated: Dec 2, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Radiomic Detection of EGFR Mutations in NSCLC.

Giovanni Rossi1,2, Emanuele Barabino3, Alessandro Fedeli4

  • 1Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Cancer Research
|November 5, 2020
PubMed
Summary
This summary is machine-generated.

This study developed a machine learning model using radiomics and clinical data to predict EGFR mutations in non-small cell lung cancer patients. The model achieved good accuracy across multiple datasets, showing potential for non-invasive mutation status identification.

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.6K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

162

Related Experiment Videos

Last Updated: Dec 2, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.6K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

162

Area of Science:

  • Radiology and Medical Imaging
  • Oncology
  • Artificial Intelligence in Medicine

Background:

  • Radiomics analysis of imaging exams can predict molecular profiles of solid tumors.
  • Identifying EGFR mutational status is crucial for non-small cell lung cancer (NSCLC) treatment decisions.

Purpose of the Study:

  • To develop a predictive algorithm for EGFR mutational status in treatment-naïve advanced NSCLC patients using radiomics.
  • To assess the model's accuracy on external validation datasets and identify radiomics features associated with treatment resistance.

Main Methods:

  • Radiomics analysis was performed on CT scans from 109 treatment-naïve NSCLC patients.
  • A machine learning model was developed incorporating radiomic and clinical features (gender, smoking status).
  • A 'test-retest' approach was used for feature stability, and the model was validated on external datasets (TCIA, another institution).

Main Results:

  • The model achieved 88.1% accuracy (AUC 0.85) in the primary dataset, with 76.6% and 83.3% accuracy in external validation sets.
  • 17 distinct radiomics features at baseline CT were associated with the development of T790M resistance during EGFR inhibitor treatment.
  • Data normalization and 'test-retest' methods improved model performance and reliability on external data.

Conclusions:

  • The machine learning model accurately identifies EGFR-mutant NSCLC patients using radiomics and clinical data.
  • Radiomics-based algorithms show promise for non-invasive prediction of molecular subtypes in NSCLC.
  • Further improvements in model accuracy are expected with more comprehensive training datasets and optimized methods.